A review of economic evaluations of tobacco control programs

International Journal of Environmental Research and Public Health

Volumn 6, Issue 1, 2009, Pages 51-68

  Kahende, Jennifer W ^a   Loomis, Brett R ^b   Adhikari, Bishwa ^a   Marshall, Latisha ^a  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^b RTI INTERNATIONAL   (United States)

Author keywords

Cost effectiveness; Economic evaluation; Smoking; Smoking cessation; Tobacco use

Indexed keywords

NICOTIANA TABACUM;

EID: 61449226533     PISSN: None     EISSN: 16604601     Source Type: Journal    
DOI: 10.3390/ijerph6010051     Document Type: Review

References (73)

1. Adhikari, B.; Kahende, J.; Malarcher, A.; Pechacek, T.; Tong, V. Smoking-attributable mortality, years of potential life lost, and productivity losses-United States, 2000-2004. MMWR Morb. Mortal Wkly Rep. 2008, 57, 1226-1228.
2. U.S Department of Health and Human Services. The health consequences of smoking: a report of the Surgeon General. U.S Department of Health and Human Services, Centers for Disease Control and Prevention: Atlanta, Georgia, U.S., 2004.
3. American Legacy Foundation. Saving lives, saving money: why states should invest in a tobacco-free future. American Legacy Foundation: Washington, DC, USA, 2002.
4. Zhang, X.; Miller, L.; Max, W.; Rice, D.P. Cost of smoking to the Medicare program, 1993. Health Care Financ. Rev. 1999, 20, 1-19.
5. Centers for Disease Control and Prevention (CDC). Best practices for comprehensive tobacco control programs. US Department of Health and Human Services: Atlanta, Georgia, U.S., 1999.
6. Campaign for Tobacco Free Kids. History on State Spending for Tobacco Prevention. Accessed May 7, 2007 at http://www.tobaccofreekids.org/reports/ settlements/2007/history.pdf.
7. US Department of Health and Human Services. Reducing tobacco use: a report of the Surgeon General. US Department of Health and Human Services, Centers for Disease Control and Prevention, Office on Smoking and Health: Atlanta, Georgia, U.S., 2000.
8. Task Force on Community Preventive Services. The guide to community preventive services: what works to promote health?; Zaza, S., Briss, P.A., Harris, K.W., Eds.; Oxford University Press: New York, NY, USA, 2005; pp. 3-79.
9. nd Ed.; Oxford University Press: New York, NY, USA, 1997.
10. nd Ed.; Oxford University Press: New York, NY, USA, 2003.
11. Gold, M.R.; Siegal, J.E.; Russell, L.B., Weinstein, M.C. Eds.; Cost effectiveness in health and medicine; Oxford University Press: New York, NY, USA, 1996.
12. Krahn, M.; Gafni, A. Discounting in the economic evaluation of health care interventions. Med. Care 1993, 31, 403-418.
13. Ahmad, S. Increasing excise taxes on cigarettes in California: a dynamic simulation of health and economic impacts. Prev. Med. 2005, 41, 276-283.
14. Fishman, P.A.; Ebel, B.E.; Garrison, M.M.; Christakis, D.A.; Wiehe, S.E.; Rivara, F.T. Cigarette tax increase and media campaign. Cost of reducing smoking-related deaths. Am. J. Prev. Med. 2005, 29, 19-26.
15. Rivara, F.P.; Ebel, B.E.; Garrison, M.M.; Christakis, D.A.; Wiehe, S.E.; Levy, D.T. Prevention of smoking-related deaths in the United States. Am. J. Prev. Med. 2004, 27, 118-125.
16. Kaplan, R.M.; Ake, C.F.; Emery, S.L.; Navarro, A.M. Simulated effect of tobacco tax variation on population health in California. Am. J. Public Health 2001, 91, 239-244.
17. Ranson, K.; Jha, P.; Chaloupka, F.J.; Nguyen, S.N. Global and regional estimates of the effectiveness and cost-effectiveness of price increases and other tobacco control policies. Nicotine Tob. Res. 2002, 4, 311-319.
18. Mudarri, D.H. The costs and benefits of smoking restrictions: an assessment of the Smoke-Free Environment Act of 1993 (H.R. 3434). United States Environmental Protection Agency, Office of Radiation and Indoor Air: Washington, DC, U.S., April 1994.
19. Ong, M.K.; Glantz, S.A. Free nicotine replacement therapy programs vs. implementing smoke-free workplaces: a cost-effectiveness comparison. Am. J. Public Health 2005, 95, 969-975.
20. Mandel, L.L.; Alamar, B.C.; Glantz, S.A. Smoke-free law did not affect revenue from gaming in Delaware. Tob. Control 2005, 14, 10-12.
21. Scollo, M.; Lal, A.; Hyland, A.; Glantz, S. Review of the quality of studies on the economic effects of smoke-free policies on the hospitality industry. Tob. Control 2003, 12, 13-20.
22. US Department of Health and Human Services. The health consequences of involuntary exposure to tobacco smoke: a report of the Surgeon General. US Department of Health and Human Services, Centers for Disease Control and Prevention, Coordinating Center for Health Promotion, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health: Atlanta, GA, 2006. Accessed July 12, 2007 at: http://www.surgeongeneral.gov/ library/reports.htm.
23. Glantz, S.A.; Smith, L. The effect of ordinances requiring smoke-free restaurants on restaurant sales. Am. J. Public Health 1994, 84, 1081-1085.
24. Glantz, S.A.; Smith, L.: The effect of ordinances requiring smoke-free restaurants and bars on revenues: a follow-up. Am. J. Public Health 1997, 87, 1687-1693.
25. Centers for Disease Control and Prevention. Assessment of the impact of a 100% smoke-free ordinance on restaurant sales - West Lake Hills, Texas, 1992-1994. MMWR Morb. Mortal Wkly Rep. 1995, 44, 370-372.
26. Centers for Disease Control and Prevention. Impact of a smoking ban on restaurant and bar revenue - El Paso, Texas, 2002. MMWR Morb. Mortal Wkly Rep. 2004, 53, 150-152.
27. Bartosch, W.J.; Pope, G.C. The economic effect of smoke-free restaurant policies on restaurant business in Masssachusetts. J Public Health Managd Pract 1999, 5, 53-62.
28. Hyland, A.; Cummings, K.M.; Nauenberg, E. Analysis of taxable sales receipts: was New York City's Smoke-Free Air Act bad for restaurant business? J. Public Health Manag. Pract. 1994, 5, 14-21.
29. Cowling, D.W.; Bond, P. Smoke-free laws and bar revenues in California-the last call. Health Econ. 2005, 14, 1273-1281.
30. Tang, H.; Cowling, D.W.; Lloyd, J.C.; Rogers, T.; Koumjian, K.L.; Stevens, C.M.; Bal, D.G. Changes of attitudes and patronage behaviors in response to a smoke-free bar law. Am. J. Public Health 2003, 93, 611-617.
31. Tang, H., Cowling, D.W.; Stevens, C.M.; Lloyd, J.C. Changes of knowledge, attitudes, beliefs, and preference of bar owner and staff in response to a smoke-free bar law. Tob. Control 2004, 13, 87-89.
32. Weber, M.D.; Bagwell, D.A.S.; Fielding, J.E.; Glantz, S.A. Long term compliance with California's smoke-free workplace law among bars and restaurants in Los Angeles County. Tob. Control 2003, 12, 269-273.
33. Curry, S.J.; Grothaus, L.C.; McAfee, T.; Pabiniak, C. Use and cost effectiveness of smoking-cessation services under four insurance plans in a health maintenance organization. N Engl. J. Med. 1998, 339, 673-679.
34. DiFranza, J.R.; Peck, R.M.; Radecki, T.E.; Savageau, J.A. What is the potential cost-effectiveness of enforcing a prohibition on the sale of tobacco to minors? Prev. Med. 2001, 32, 168-174.
35. Ratcliffe, J.; Cairns, J.; Platt, S. Cost effectiveness of a mass media-led anti-smoking campaign in Scotland. Tob. Control 1997, 6, 104-110.
36. Secker-Walker, R.H.; Worden, J.K.; Holland, R.R.; Flynn, B.S.; Detsky, A.S. A mass media programme to prevent smoking among adolescents: costs and cost effectiveness. Tob. Control 1997, 6, 207-212.
37. Secker-Walker, R.H.; Holland, R.R.; Lloyd, C.M.; Pelkey, D.; Flynn, B.S. Cost effectiveness of a community based research project to help women quit smoking. Tob. Control 2005, 14, 37-42.
38. Tran, M.T.; Holdford, D.A.; Kennedy, D.T.; Small, R.E. Modeling the cost-effectiveness of a smoking-cessation program in a community pharmacy practice. Pharmacotherapy 2002, 22, 1623-1631.
39. Crealey, G.E.; McElnay, J.C.; Maguire, T.A.; O'Neill, C. Costs and effects associated with a community pharmacy-based smoking-cessation programme. Pharmacoeconomics 1998, 14, 323-333.
40. McAlister, A.L.; Rabius, V.; Geiger, A.; Glynn, T.J.; Huang, P.; Todd, R. Telephone assistance for smoking cessation: one year cost effectiveness estimations. Tob. Control 2004, 13, 85-86.
41. Tomson, T.; Helgason, A.; Gilljam, H. Quitline in smoking cessation: a cost-effectiveness analysis. Int. J. Technol. Assess. Health Care 2004, 40, 469-474.
42. Tengs, T.O.; Osgood, N.D.; Chen, L.L. The cost-effectiveness of intensive national school-based anti-tobacco education: results from the tobacco policy model. Prev. Med. 2001, 33, 558-570.
43. Wang, L.Y.; Crossett, L.S.; Lowry, R.; Sussman, S.; Dent, C.W. Cost-effectiveness of a school-based tobacco-use prevention program. Arch. Pediatr. Adoles. Med. 2001, 155, 1043-1050.
44. Croghan, I.T.; Offord, K.P.; Evans, R.W.; Schmidt, S.; Gomez-Dahl, L.C.; Schroeder, D.R.; Patten, C.A.; Hurt. R.D. Cost-effectiveness of treating nicotine dependence: the Mayo Clinic experience. Mayo. Clin. Proc. 1997, 72, 917-924.
45. Friscella, K.; Franks, P. Cost-effectiveness of the transdermal nicotine patch as an adjunct to physicians' smoking cessation counseling. JAMA-J. Am. Med. Assn. 1996, 275, 1247-1251.
46. Gilbert, A.R.; Pinget, C.; Bovet, P.; Cornuz, J.; Shamlaye, C.; Paccaud, F. The cost effectiveness of pharmacological smoking cessation therapies in developing countries: a case study in the Seychelles. Tob. Control 2004, 13, 190-195.
47. Hughes, J.R.; Wadland, W.C.; Fenwick, J.W.; Lewis, J.; Bickel,W. Effect of cost on the self-administration and efficacy of nicotine gum: a preliminary study. Prev. Med. 1991, 20, 486-496.
48. Stapleton, J.A.; Lowin, A.; Russell, M.A.H. Prescription of transdermal nicotine patches for smoking cessation in general practice: evaluation of cost-effectiveness. Lancet North Am. Ed. 1999, 354, 210-215.
49. Wasley, M.A.; McNagny, S.E.; Phillips, V.L.; Phil, D.; Ahluwalia, J. The cost-effectiveness of the nicotine transdermal patch for smoking cessation. Prev. Med. 1997, 26, 264-270.
50. Woolacott, N.F.; Jones, L.; Forbes, C.A.; Mather, L.C.; Sowden, A.J.; Song, F.J.; Raftery, J.P.; Aveyard, P.N.; Hyde, C.J.; Barton, P.M. The clinical effectiveness and cost-effectiveness of bupropion and nicotine replacement therapy for smoking cessation: a systematic review and economic evaluation. Health Technol. Assess. 2002, 6, 1-245.
51. Cromwell, J.; Bartosch, W.J.; Fiore, M.C.; Hasselblad, B.; Baker, T. Cost-effectiveness of the clinical practice recommendations in the AHCPR guideline for smoking cessation. JAMA-J. Am. Med. Assn. 1997, 275, 1759-1766.
52. The Agency for Health Care Policy and Research. Smoking Cessation Clinical Practice Guideline. JAMA-J. Am. Med. Assn. 1996, 275, 1270-1280.
53. Cummings, S.R.; Rubin, S.M.; Oster, G. The cost-effectiveness of counseling smokers to quit. JAMA-J. Am. Med. Assn. 1989, 261, 75-79.
54. Krumholz, H.M.; Cohen, B.J.; Tsevat, J.; Pasternak, R.; Weinstein, M.C. Cost-effectiveness of a smoking cessation program after myocardial infarction. J. Am. Coll. Cardiol. 1993, 22, 1697-1702.
55. 55.Meenan, R.T.; Stevens, V.J.; Hornbrook, M.C.; La Chance, P.A.; Glasgow, R.E.; Hollis, J.F.; Lichtenstein, E.; Vogt, T.M. Cost-effectiveness of a hospital-based smoking cessation intervention. Med. Care 1998, 36, 670-678.
56. Ershoff, D.H.; Aaronson, N.K.; Danaher, B.G.; Wasserman, F.W. Behavioral, health, and cost outcomes of an HMO-based prenatal health education program. Public Health Rep. 1983, 98, 536-547.
57. Ershoff, D.H.; Quinn, V.P. Mullen, P.D.; Lairson, D.R. Pregnancy medical cost outcomes of a self-help prenatal smoking cessation program in an HMO. Public Health Rep. 1990, 105, 340-348.
58. Hueston, W.J.; Mainous, A.G.; Farrell, J.B. A cost-benefit analysis of smoking cessation programs during the first trimester of pregnancy for the prevention of low birthweight. J Fam Pract 1994, 39, 353-358.
59. Marks, J.S.; Koplan, J.P.; Hogue, C.J.R.; Dalmat, M.E. A cost-benefit/cost-effectiveness analysis of smoking cessation for pregnant women. Am. J. Prev. Med. 1990, 6, 282-289.
60. Pollack, H.A. Sudden infant death syndrome, maternal smoking during pregnancy, and the cost-effectiveness of smoking cessation intervention. Am. J. Public Health 2001, 91, 432-436.
61. Shipp, M.; Croughan-Minihane, M.S.; Petitti, D.B.; Washington, A.E. Estimation of the breakeven point for smoking cessation programs in pregnancy. Am. J. Public Health 1992, 82, 383-390.
62. Lennox,A.S.; Osman, L.M.; Reiter, E.; Robertson, R.; Friend, J.; McCann, I.; Skatun, D.; Donnan, P.T. Cost effectiveness of computer tailored and non-tailored smoking cessation letters in general practice: randomized controlled trial. BMJ 2001, 322, 1-7.
63. Mudde, A.N.; De Vries, H.; Strecher, V.J. Cost-effectiveness of smoking cessation modalities: comparing apples with oranges? Prev. Med. 1996, 25, 708-716.
64. Brandon, T.H.; Meade, C.D.; Herzog, T.A.; Chirikos, T.N.; Webb, M.S.; Cantor, A.B. Efficacy and cost-effectiveness of a minimal intervention to prevent smoking relapse: dismantling the effects of amount of content versus content. J. Consult Clin. Psychol. 2004, 72, 797-808.
65. Cohen, D.R.; Fowler, G.H. Economic implications of smoking cessation therapies: a review of economic appraisals. Pharmacoeconomics 1993, 4, 331-344.
66. Warner, K.E. Cost effectiveness of smoking-cessation therapies. Pharmacoeconomics 1997, 11, 538-549.
67. Elixhauser, A. The costs of smoking and the cost effectiveness of smoking-cessation programs. J. Public Health Policy 1990, 11, 218-237.
68. Friend, K.; Levy, D. Smoking cessation interventions and policies to promote their use: a critical review. Nicotine Tob. Res. 2001, 3, 299-310.
69. Commonwealth Department of Health and Aging. Returns on investment in public health: an epidemiological and economic analysis (2003). Accessed August 8, 2007 at http://www.health.gov.au/internet/wcms/publishing.nsf/Content/ 19B2B27E06797B79CA256F190 004503C/$File/roi-eea.pdf.
70. Weiss, S.J.; Jurs, S.; Lessage, J.P.; Iverson, D.C. A cost-benefit analysis of a smoking cessation program. Eval. program plan. 1984, 7, 337-346.
71. Tauras, J.A.; Chaloupka, F.J.; Farrelly, M.C.; Giovino, G.A.; Wakefield, M.; Johnston, L.D.; O'malley, P.M.; Kloska, D.D.; Pechacek, T.F. State tobacco control spending and youth smoking. Am. J. Public Health 2005, 95, 338-344.
72. Stone, P.W.; Teutsch, S.; Chapman, R.H.; Bell, C.; Goldie, S.J.; Numann, P.J. Cost-utility analyses of clinical preventive services. Am. J. Prev. Med. 2000, 19, 15-23.
73. Maciosek, M.V.; Coffield, A.B.; Edwards, N.M.; Flottemesch, T.J.; Goodman, M.J.; Solberg, L.I. Priorities among effective clinical preventive services: results of a systematic review and analysis. Am. J. Prev. Med. 2006, 31, 52-61.